News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
644,357 Results
Type
Article (55461)
Company Profile (69)
Press Release (588827)
Multimedia
Podcasts (70)
Webinars (12)
Section
Business (172745)
Career Advice (2733)
Deals (32557)
Drug Delivery (101)
Drug Development (78253)
Employer Resources (158)
FDA (15055)
Job Trends (13908)
News (305980)
Policy (29526)
Tag
Academia (2579)
Academic (2)
Accelerated approval (6)
Adcomms (22)
Allergies (90)
Alliances (42576)
ALS (88)
Alzheimer's disease (1296)
Antibody-drug conjugate (ADC) (116)
Approvals (15064)
Artificial intelligence (264)
Autoimmune disease (24)
Automation (15)
Bankruptcy (294)
Best Places to Work (10916)
BIOSECURE Act (18)
Biosimilars (102)
Biotechnology (46)
Bladder cancer (81)
Brain cancer (28)
Breast cancer (275)
Cancer (2247)
Cardiovascular disease (170)
Career advice (2317)
Career pathing (33)
CAR-T (156)
Cell therapy (442)
Cervical cancer (19)
Clinical research (63723)
Collaboration (790)
Company closure (1)
Compensation (331)
Complete response letters (22)
COVID-19 (2434)
CRISPR (46)
C-suite (260)
Cystic fibrosis (100)
Data (2170)
Decentralized trials (2)
Denatured (28)
Depression (43)
Diabetes (256)
Diagnostics (6182)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (42)
Drug discovery (118)
Drug pricing (102)
Drug shortages (23)
Duchenne muscular dystrophy (84)
Earnings (60923)
Editorial (40)
Employer branding (19)
Employer resources (138)
Events (97675)
Executive appointments (758)
FDA (16322)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (739)
Gene editing (114)
Generative AI (20)
Gene therapy (305)
GLP-1 (669)
Government (4521)
Grass and pollen (6)
Guidances (64)
Healthcare (18354)
Huntington's disease (19)
IgA nephropathy (27)
Immunology and inflammation (118)
Indications (29)
Infectious disease (2568)
Inflammatory bowel disease (136)
Inflation Reduction Act (9)
Influenza (53)
Intellectual property (96)
Interviews (529)
IPO (14893)
IRA (40)
Job creations (3386)
Job search strategy (1942)
Kidney cancer (11)
Labor market (30)
Layoffs (507)
Leadership (22)
Legal (6513)
Liver cancer (72)
Lung cancer (317)
Lymphoma (151)
Machine learning (7)
Management (55)
Manufacturing (281)
MASH (65)
Medical device (12636)
Medtech (12641)
Mergers & acquisitions (18245)
Metabolic disorders (645)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (85)
Neuropsychiatric disorders (26)
Neuroscience (1822)
NextGen: Class of 2025 (6413)
Non-profit (4464)
Now hiring (9)
Obesity (333)
Opinion (233)
Ovarian cancer (70)
Pain (92)
Pancreatic cancer (81)
Parkinson's disease (145)
Partnered (21)
Patents (234)
Patient recruitment (112)
Peanut (50)
People (58504)
Pharmaceutical (23)
Pharmacy benefit managers (17)
Phase I (19895)
Phase II (28034)
Phase III (20728)
Pipeline (1161)
Policy (135)
Postmarket research (2559)
Preclinical (8578)
Press Release (62)
Prostate cancer (108)
Psychedelics (27)
Radiopharmaceuticals (254)
Rare diseases (371)
Real estate (5922)
Recruiting (63)
Regulatory (20574)
Reports (33)
Research institute (2265)
Resumes & cover letters (406)
Rett syndrome (5)
RNA editing (4)
RSV (37)
Schizophrenia (67)
Series A (131)
Series B (85)
Service/supplier (9)
Sickle cell disease (54)
Special edition (12)
Spinal muscular atrophy (146)
Sponsored (27)
Startups (3235)
State (1)
Stomach cancer (10)
Supply chain (57)
Tariffs (26)
The Weekly (40)
Vaccines (652)
Venture capitalists (35)
Weight loss (209)
Women's health (33)
Worklife (19)
Date
Last 7 days (830)
Last 30 days (2349)
Last 365 days (30651)
2025 (10266)
2024 (32650)
2023 (36708)
2022 (46988)
2021 (51810)
2020 (50791)
2019 (45042)
2018 (34225)
2017 (30624)
2016 (29957)
2015 (35227)
2014 (28374)
2013 (24533)
2012 (25900)
2011 (26204)
2010 (24887)
Location
Africa (852)
Alabama (55)
Alaska (7)
Arizona (175)
Arkansas (13)
Asia (37493)
Australia (6617)
California (5597)
Canada (1844)
China (498)
Colorado (251)
Connecticut (267)
Delaware (142)
Europe (87266)
Florida (846)
Georgia (197)
Idaho (56)
Illinois (541)
India (25)
Indiana (286)
Iowa (9)
Japan (153)
Kansas (97)
Kentucky (25)
Louisiana (10)
Maine (60)
Maryland (860)
Massachusetts (4083)
Michigan (220)
Minnesota (338)
Mississippi (2)
Missouri (88)
Montana (30)
Nebraska (22)
Nevada (59)
New Hampshire (61)
New Jersey (1652)
New Mexico (30)
New York (1621)
North Carolina (946)
North Dakota (8)
Northern California (2425)
Ohio (194)
Oklahoma (15)
Oregon (35)
Pennsylvania (1236)
Puerto Rico (12)
Rhode Island (28)
South America (1196)
South Carolina (24)
South Dakota (1)
Southern California (2135)
Tennessee (96)
Texas (851)
United States (21420)
Utah (171)
Virginia (141)
Washington D.C. (56)
Washington State (513)
West Virginia (3)
Wisconsin (59)
644,357 Results for "american society of transplantation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Hansa Biopharma to present data at 2024 American Transplant Congress annual meeting
. Hansa Biopharma, “Hansa”, announced data featuring imlifidase will be presented at the American Transplant Congress, the joint annual meeting of the American Society of Transplant Surgeons and the American Society of Transplantation.
May 21, 2024
·
7 min read
Genetown
Invivyd to Present Data at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting and 2024 American Transplant Congress (ATC)
Invivyd, Inc. announced that it will present preliminary, subset analyses from the CANOPY Phase 3 clinical trial of VYD222 for pre-exposure prophylaxis of COVID-19 at the 2024 American Society of Clinical Oncology Annual Meeting and at the 2024 American Transplant Congress.
May 29, 2024
·
1 min read
Press Releases
TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 28th Annual Meeting
April 28, 2025
·
2 min read
Press Releases
4M Therapeutics to Present at the Upcoming American Psychological Association and American Society of Clinical Psychopharmacology Annual Meetings
April 21, 2025
·
1 min read
Press Releases
Endeavor BioMedicines Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference
May 1, 2025
·
2 min read
Press Releases
SELLAS to Present at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2025
·
3 min read
Press Releases
Calluna Announces Three Poster Presentations at the 2025 American Thoracic Society International Conference
April 29, 2025
·
2 min read
Press Releases
Vicore Announces Presentations at the 2025 American Thoracic Society International Conference
April 23, 2025
·
4 min read
Press Releases
FORE Biotherapeutics to Present Plixorafenib Abstract at the 2025 American Society of Clinical Oncology Annual Meeting
April 30, 2025
·
1 min read
Press Releases
nChroma Bio to Present at the American Society of Gene & Cell Therapy (ASGCT) 2025 Annual Meeting
April 28, 2025
·
2 min read
1 of 64,436
Next
